Cellyan Biotechnology Co., Ltd
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $9.6M
- Price
- $0.4087
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.07%
- Volume
- 120.7K
About
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Quick stats
Shares outstanding23.5M
Computed float3.9M
Float / shares16.5%
Key info
SectorHealthcare
IndustryMedical - Distribution
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002007702
Websitehttp://www.9zt.hk
AI Summary
AI-generated1mo agostandardbearishregulatory
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
Cellyan Biotechnology received a Nasdaq notification granting an additional 180-day grace period, expiring January 11, 2027, to regain compliance with the minimum $1.00 closing bid price requirement.
To cure the deficiency, the company must maintain a bid price of at least $1.00 for ten consecutive business days, though it noted a reverse share split may be necessary if natural price recovery fails.
Trading continues uninterrupted under ticker HKPD, but the company warned it cannot provide assurance that compliance will be restored.
Red flags
- Stock trading below $1.00 minimum bid price
- Potential reverse share split mentioned to regain compliance
- No assurance of regaining compliance